Development of new indicators for the launch of a Japanese version of the NIH (2) : A technology-specific overview and future prospects of pharmaceutical industry

Abstract

For the sake of providing evidences that contribute to policy making or strategy planning in a Japanese version of the NIH and pharmaceutical companies, we tried an overview and future prospects of pharmaceutical industry based on new indicators. Focusing on Bio-medicine which has high future growth potential, we analyzed the strengths and weaknesses of each country in each technology field. Consequently, the results showed the competitive advantage of U. S. in the R&D of Bio-medicine. We also indicated the strengths of Japan in some field of Biotechnology.